This report is for educational purposes only, and not to provide investment advice.  Before making any investment decision, you should always do your own research or consult a investment professional.
While I try to be accurate, I assume no responsibility for any figure in this spreadsheet. Estimates Estimates Estimates
See my website on stocks or see my blog at the following sites.  https://spbrunner.com/stocks.html https://spbrunner.blogspot.com/ Q1 2023
HLS Therapeutics Inc TSXV HLS OTC HLTRF http://www.hlstherapeutics.com/ Fiscal Yr: Dec-31
Year 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15 31-Dec-16 31-Dec-17 31-Dec-18 31-Dec-19 31-Dec-20 31-Dec-21 31-Dec-22 31-Dec-23 31-Dec-24 1-Jan-26 Value Description #Y Item Total G Currency
Accounting Rules IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS IFRS Accounting Rules
USD - CDN$ 0.9946 1.0170 0.9949 1.0636 1.1601 1.3847 1.3427 1.2545 1.3642 1.2988 1.2732 1.2678 1.3544 1.3623 1.3623 1.3623 24.66% <-Total Growth 10 Currency
Change -4.97% 2.25% -2.17% 6.91% 9.07% 19.36% -3.04% -6.57% -6.57% 8.74% -4.79% -1.97% -0.42% 6.83% 0.58% 0.00% 2.23% <-IRR #YR-> 10 USD - CDN$
5 year Running Average 1.0838 1.0542 1.0555 1.0233 1.0460 1.1241 1.1892 1.2411 1.3012 1.3290 1.3067 1.2917 1.3117 1.3113 1.3240 -1.14% <-IRR #YR-> 5 USD - CDN$
-1.0170 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 1.2678
-1.3427 0.0000 0.0000 0.0000 0.0000 1.2678
-$38.332 <-12 mths -162.36%
Revenue US$* $19.956 $54.031 $75.082 $61.415 $54.160 $56.109 $60.009 $61.467 $66 $97 $136 13.76% <-Total Growth 7 Revenue US$
Increase 170.75% 38.96% -18.20% -11.81% 3.60% 6.95% 2.43% 7.37% 47.58% 39.63% 17.43% <-IRR #YR-> 7 Revenue #DIV/0! US$
5 year Running Average $52.929 $60.159 $61.355 $58.632 $59.549 $68.197 $84.175 -3.92% <-IRR #YR-> 5 Revenue -18.13% US$
Revenue per Share $0.86 $2.14 $2.97 $2.25 $1.74 $1.76 $1.85 $1.90 $2.04 $3.01 $4.20 3.47% <-IRR #YR-> 3 5 yr Running Average #DIV/0! US$
Increase 38.96% -24.25% -22.50% 1.11% 4.88% 2.73% 7.37% 47.58% 39.63% 3.47% <-IRR #YR-> 3 5 yr Running Average #DIV/0! US$
5 year Running Average $1.99 $2.17 $2.12 $1.90 $1.86 $2.11 $2.60 12.04% <-IRR #YR-> 7 Revenue per Share #DIV/0! US$
P/S (Price/Sales) Med 10.66 4.12 2.97 4.12 8.79 8.29 7.41 4.80 2.69 0.00 0.00 -8.55% <-IRR #YR-> 5 Revenue per Share -36.04% US$
P/S (Price/Sales) Close 9.66 3.57 2.57 5.17 10.88 7.85 6.24 3.82 1.60 1.09 2.94 -1.54% <-IRR #YR-> 3 5 yr Running Average #DIV/0! US$
*Revenue in M US $  P/S Med 10 yr  6.10 5 yr  7.41 -73.73% Diff M/C -1.54% <-IRR #YR-> 3 5 yr Running Average #DIV/0! US$
-$20 $0 $0 $0 $0 $0 $0 $61
-$75 $0 $0 $0 $0 $61
-$53 $0 $0 $59
-$53 $0 $0 $59
-$0.86 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.90
-$2.97 $0.00 $0.00 $0.00 $0.00 $1.90
-$1.99 $0.00 $0.00 $1.90
-$1.99 $0.00 $0.00 $1.90
-$52.220 <-12 mths -162.73%
Revenue CDN $ $27.634 $72.547 $94.190 $83.782 $70.343 $71.438 $76.079 $83.251 $90 $133 $185 14.75% <-Total Growth 7 Revenue CDN$
Increase 29.83% -11.05% -16.04% 1.56% 6.50% 9.43% 8.00% 47.58% 39.63% 17.06% <-IRR #YR-> 7 Revenue #DIV/0! CDN$
5 year Running Average $69.699 $78.460 $79.167 $76.979 $78.205 $90.674 $113.441 -2.44% <-IRR #YR-> 5 Revenue -11.61% CDN$
Revenue per Share $1.19 $2.87 $3.73 $3.07 $2.26 $2.24 $2.34 $2.57 $2.78 $4.10 $5.73 3.37% <-IRR #YR-> 3 5 yr Running Average #DIV/0! CDN$
Increase 29.83% -17.62% -26.22% -0.88% 4.43% 9.75% 8.00% 47.58% 39.63% 3.37% <-IRR #YR-> 3 5 yr Running Average #DIV/0! CDN$
5 year Running Average $2.62 $2.84 $2.73 $2.50 $2.44 $2.81 $3.50 11.68% <-IRR #YR-> 7 Revenue per Share #DIV/0! CDN$
P/S (Price/Sales) Med 10.66 4.12 2.97 3.97 8.50 8.25 7.51 4.71 2.66 0.73 0.00 -7.14% <-IRR #YR-> 5 Revenue per Share -30.95% CDN$
P/S (Price/Sales) Close 9.66 3.57 2.57 4.77 11.26 8.02 6.40 3.82 1.53 1.03 2.94 -1.60% <-IRR #YR-> 3 5 yr Running Average #DIV/0! CDN$
*Revenue in M CDN $  P/S Med 10 yr  6.11 5 yr  7.51 -75.04% Diff M/C -1.60% <-IRR #YR-> 3 5 yr Running Average #DIV/0! CDN$
-$28 $0 $0 $0 $0 $0 $0 $83
-$94 $0 $0 $0 $0 $83
-$70 $0 $0 $77
-$70 $0 $0 $77
-$1.19 $0 $0 $0 $0 $0 $0.00 $2.57
-$3.73 $0 $0 $0 $0.00 $2.57
-$2.62 $0.00 $0.00 $2.50
-$2.62 $0.00 $0.00 $2.50
-$0.80 <-12 mths -9.59%
EPS Basic US$ -$0.92 -$0.60 -$0.24 -$0.92 -$0.67 -$0.48 -$0.41 -$0.73 -21.67% <-Total Growth 7 EPS Basic
EPS Diluted* US$ -$0.92 -$0.60 -$0.24 -$0.92 -$0.67 -$0.48 -$0.41 -$0.73 -$0.48 -$0.10 $0.04 -21.67% <-Total Growth 7 EPS Diluted US$
Increase 34.78% 60.00% -283.33% 27.17% 28.36% 14.58% -78.05% 34.25% 79.17% 140.00% 0 8 8 Years of Data, EPS P or N
Earnings Yield -7.9% -3.1% -7.9% -3.5% -3.5% -3.6% -10.1% -14.7% -3.1% 0.3% -3.25% <-IRR #YR-> 7 Earnings per Share 20.65% US$
5 year Running Average -$0.67 -$0.58 -$0.54 -$0.64 -$0.55 -$0.44 -$0.34 24.92% <-IRR #YR-> 5 Earnings per Share 20.65% US$
10 year Running Average -$0.50 -$0.55 -$0.56 -$0.46 -1.41% <-IRR #YR-> 3 5 yr Running Average #DIV/0! US$
* Diluted ESP per share US$ E/P 10 Yrs -3.55% 5Yrs -3.55% -1.41% <-IRR #YR-> 3 5 yr Running Average #DIV/0! US$
$0.92 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$0.73
$0.24 $0.00 $0.00 $0.00 $0.00 -$0.73
$0.67 $0.00 $0.00 -$0.64
$0.67 $0.00 $0.00 -$0.64
-$1.08 <-12 mths 9.59%
EPS Basic CDN$ -$1.27 -$0.81 -$0.30 -$1.26 -$0.87 -$0.61 -$0.52 -$0.99 21.22% <-Total Growth 7 EPS Basic CDN$
EPS Diluted   -$1.27 -$0.81 -$0.30 -$1.26 -$0.87 -$0.61 -$0.52 -$0.99 -$0.65 -$0.14 $0.05 21.22% <-Total Growth 7 EPS Diluted CDN$
Increase 36.76% 62.63% -316.85% 30.67% 29.77% 14.95% -90.21% 33.86% 79.17% 140.00% 0 8 8 Years of Data, EPS P or N
Earnings Yield -7.9% -3.1% -8.6% -3.4% -3.4% -3.5% -10.1% -15.4% -3.2% 0.3% -3.56% <-IRR #YR-> 7 Earnings per Share 21.22% CDN$
5 year Running Average -$0.90 -$0.77 -$0.71 -$0.85 -$0.73 -$0.58 -$0.45 26.85% <-IRR #YR-> 5 Earnings per Share -228.39% CDN$
10 year Running Average -$0.66 -$0.73 -$0.74 -$0.61 -1.97% <-IRR #YR-> 3 5 yr Running Average #DIV/0! CDN$
* Diluted ESP per share  E/P 10 Yrs -3.47% 5Yrs -3.47% -1.97% <-IRR #YR-> 3 5 yr Running Average #DIV/0! CDN$
$1.27 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$0.99
$0.30 $0.00 $0.00 $0.00 $0.00 -$0.99
$0.90 $0.00 $0.00 -$0.85
$0.90 $0.00 $0.00 -$0.85
Dividends* US$ $0.15 Estimates Dividend*
Increase -0.58% Estimates Increase
Payout Ratio EPS -30.59% Estimates Payout Ratio EPS
Real Dividend is  $0.04
Special Dividend US$ $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 0.00% <-Median-> 5 Special Dividends  US$
Dividends* US$ $0.04 $0.15 $0.16 $0.16 $0.15 $0.15 $0.15 $0.15 -4.11% <-Total Growth 4 Dividends US$
Increase 320.14% 2.01% 0.43% -6.39% -0.58% 0.00% 0.00% 3 1 4 Years of data, Count P, N US$
Average Increases 5 Year Running 64.4% 64.5% 63.2% 63.1% -0.9% -1.3% 64.43% <-Median-> 3 Average Incr 5 Year Running US$
Dividends 5 Yr Running $0.12 $0.13 $0.16 $0.15 $0.15 $0.15 29.21% <-Total Growth 2 Dividends 5 Yr Running US$
Yield H/L Price 0.40% 1.01% 1.07% 1.15% 1.62% 2.68% 1.07% <-Median-> 5 Yield H/L Price US$
Yield on High  Price 0.30% 0.77% 0.82% 0.93% 1.23% 1.91% 0.82% <-Median-> 5 Yield on High  Price US$
Yield on Low Price 0.58% 1.43% 1.55% 1.52% 2.37% 4.46% 1.52% <-Median-> 5 Yield on Low Price US$
Yield on Close Price 0.32% 0.81% 1.14% 1.37% 2.04% 4.49% 4.49% 1.19% 1.14% <-Median-> 5 Yield on Close Price US$
Payout Ratio EPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 367.03% 0.00% <-Median-> 5 DPR EPS US$
DPR EPS 5 Yr Running 0.00% 0.00% 0.00% #NUM! <-Median-> 0 DPR EPS 5 Yr Running US$
Payout Ratio CFPS 3.05% 18.11% 53.50% 31.16% 28.20% 31.24% #VALUE! #DIV/0! 28.20% <-Median-> 5 DPR CF US$
DPR CF 5 Yr Running 13.54% 16.10% 24.20% 28.87% #VALUE! #DIV/0! 16.10% <-Median-> 3 DPR CF 5 Yr Running US$
Payout Ratio CFPS WC 3.81% 19.24% 29.39% 27.31% 31.04% 37.48% #VALUE! #DIV/0! 27.31% <-Median-> 5 DPR CF WC US$
DPR CF WC 5 Yr Running 13.54% 14.75% 24.36% 27.46% #VALUE! #DIV/0! 14.75% <-Median-> 0 DPR CF WC 5 Yr Running US$
Mediuan 5 Yrs 5 Yr Med 5 Yr Cl 1.11% 1.20% 5 Yr Med Payout 0.00% 24.64% 23.28% 0.18% <-IRR #YR-> 4 Dividends #DIV/0! US$
* Dividends per share US$, paid in CDN$ 5 Yr Med and Cur. 26.74% 17.77% Last Div Inc --->< $0.05 5.0% 0.0% 0.18% <-IRR #YR-> 4 Dividends #DIV/0! US$
-$0.15 $0.00 $0.00 $0.00 $0.15
-$0.15 $0.00 $0.00 $0.00 $0.15
Historical Dividends Historical High Div 1.71% Low Div 0.68% Ave Div 1.20% Med Div 1.07% Close Div 1.14% Historical Dividends US$
High/Ave/Median Values Curr diff Cheap 162.55%     560.24% Cheap 275.70% Cheap 319.59% Cheap 295.56% High/Ave/Median  US$
Future Dividend Yield Div Yd $0.05 earning in 5 Years at IRR of 0.18% Div Inc. 0.91% Future Dividend Yield US$
Future Dividend Yield Div Yd 4.57% earning in 10 Years at IRR of 0.18% Div Inc. 1.82% Future Dividend Yield US$
Future Dividend Yield Div Yd 4.61% earning in 15 Years at IRR of 0.18% Div Inc. 2.74% Future Dividend Yield US$
Future Dividend Paid Div Paid $0.15 earning in 5 Years at IRR of 0.18% Div Inc. 0.91% Future Dividend Paid
Future Dividend Paid Div Paid $0.15 earning in 10 Years at IRR of 0.18% Div Inc. 1.82% Future Dividend Paid
Future Dividend Paid Div Paid $0.15 earning in 15 Years at IRR of 0.18% Div Inc. 2.74% Future Dividend Paid
Dividend Covering Cost Total Div $0.74 over 5 Years at IRR of 0.18% Div Cov. 22.53% Dividend Covering Cost
Dividend Covering Cost Total Div $1.33 over 10 Years at IRR of 0.18% Div Cov. 40.73% Dividend Covering Cost
Dividend Covering Cost Total Div $1.93 over 15 Years at IRR of 0.18% Div Cov. 59.10% Dividend Covering Cost
Dividends CDN$ $0.20 Estimates Dividend*
Increase 0.00% Estimates Increase
Payout Ratio EPS -30.59% Estimates Payout Ratio EPS
Real Dividend is  $0.05
Special Dividends CDN$, Paid in CDN$ $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 0.00% <-Median-> 5 Special Dividends CDN$ CDN$
Dividends per Share $0.05 $0.20 $0.20 $0.20 $0.20 $0.20 $0.20 $0.20 0.00% <-Total Growth 4 Dividends CDN$
Increase 300.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1 0 4 Years of data, Count P, N CDN$
Average Increases 5 Year Running 0.0% 60.0% 60.0% 60.0% 60.0% 60.0% 0.0% 0.0% 60.00% <-Median-> 5 Average Incr 5 Year Running CDN$
Dividends 5 Yr Running $0.15 $0.16 $0.17 $0.20 $0.20 $0.20 4.62% <-Total Growth 2 Dividends 5 Yr Running CDN$
Yield H/L Price 0.41% 1.04% 1.08% 1.14% 1.65% 2.70% 1.08% <-Median-> 5 Yield H/L Price CDN$
Yield on High  Price 0.31% 0.78% 0.85% 0.94% 1.26% 1.94% 0.85% <-Median-> 5 Yield on High  Price CDN$
Yield on Low Price 0.62% 1.54% 1.48% 1.44% 2.38% 4.44% 1.48% <-Median-> 5 Yield on Low Price CDN$
Yield on Close Price 0.34% 0.78% 1.11% 1.33% 2.03% 4.72% 4.72% 1.19% 1.11% <-Median-> 5 Yield on Close Price CDN$
Payout Ratio EPS 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 367.03% 0.00% <-Median-> 5 DPR EPS CDN$
DPR EPS 5 Yr Running 0.00% 0.00% 0.00% #NUM! <-Median-> 0 DPR EPS 5 Yr Running CDN$
Payout Ratio CFPS 3.05% 18.11% 53.50% 31.16% 28.20% 31.24% #VALUE! #DIV/0! 28.20% <-Median-> 5 DPR CF CDN$
DPR CF 5 Yr Running 19.03% 28.82% #VALUE! #DIV/0! 19.03% <-Median-> 1 DPR CF 5 Yr Running CDN$
Payout Ratio CFPS WC 3.81% 19.24% 29.39% 27.31% 31.04% 37.48% #VALUE! #DIV/0! 27.31% <-Median-> 5 DPR CF WC CDN$
DPR CF WC 5 Yr Running 27.55% #VALUE! #DIV/0! #NUM! <-Median-> 0 DPR CF WC 5 Yr Running CDN$
Mediuan 5 Yrs 10 Yr Med 10 Yr Cl 1.08% 1.11% 5 Yr Med 5 Yr Cl 1.08% 1.11% 5 Yr Med Payout 0.00% 28.20% 27.31% 0.00% <-IRR #YR-> 4 Dividends #DIV/0! CDN$
 Div per share (Dividends paid in CDN$.) 10 Yr Med and Cur. 337.03% 324.53% 5 Yr Med and Cur. 337.03% 324.53% Last Div Inc ---> $0.05 $0.05 0.0% 0.00% <-IRR #YR-> 4 Dividends #DIV/0! CDN$
-$0.20 $0.00 $0.00 $0.00 $0.20
-$0.20 $0.00 $0.00 $0.00 $0.20
Historical Dividends Historical High Div 2.21% Low Div 0.40% 10 Yr High 2.21% 10 Yr Low 0.40% Med Div 1.08% Close Div 1.11% Historical Dividends CDN$
High/Ave/Median Values Curr diff Cheap 113.44%     1079.25% Cheap 113.44% -100.00% Cheap 336.76% Cheap 324.53% High/Ave/Median  CDN$
Future Dividend Yield Div Yd 4.72% earning in 5.00 Years at IRR of 0.00% Div Inc. 0.00% Future Dividend Yield CDN$
Future Dividend Yield Div Yd 4.72% earning in 10.00 Years at IRR of 0.00% Div Inc. 0.00% Future Dividend Yield CDN$
Future Dividend Yield Div Yd $0.05 earning in 15.00 Years at IRR of 0.00% Div Inc. 0.00% Future Dividend Yield
Future Dividend Paid Div Paid $0.20 earning in 5 Years at IRR of 0.00% Div Inc. 0.00% Future Dividend Paid
Future Dividend Paid Div Paid $0.20 earning in 10 Years at IRR of 0.00% Div Inc. 0.00% Future Dividend Paid
Future Dividend Paid Div Paid $0.20 earning in 15 Years at IRR of 0.00% Div Inc. 0.00% Future Dividend Paid
Dividend Covering Cost Total Div $1.00 over 5 Years at IRR of 0.00% Div Cov. 23.58% Dividend Covering Cost
Dividend Covering Cost Total Div $1.80 over 10 Years at IRR of 0.00% Div Cov. 42.45% Dividend Covering Cost
Dividend Covering Cost Total Div $2.60 over 15 Years at IRR of 0.00% Div Cov. 61.32% Dividend Covering Cost
Yield if held 5 years 1.58% 1.69% 1.81% 1.64% 1.04% 1.08% 1.69% <-Median-> 3 Paid Median Price CDN$
Yield if held 10 years 1.58% #NUM! <-Median-> 0 Paid Median Price CDN$
Cost covered if held 5 years 3.56% 5.49% 7.69% 8.21% 5.19% 5.40% 5.49% <-Median-> 3 Paid Median Price CDN$
Cost covered if held 10 years 11.46% #NUM! <-Median-> 0 Paid Median Price CDN$
Yr  Item Tot. Growth Per Year
Revenue Growth US$ $75.1 $61.4 $54.2 $56.1 $60.0 $61.5 $368.2 -18.13% <-Total Growth 5 Revenue Growth US$ -18.13% -3.92%
EPS Growth -$0.24 -$0.92 -$0.67 -$0.48 -$0.41 -$0.73 -$3.45 0.00% <-Total Growth 5 EPS Growth 0.00% 0.00%
Net Income Growth -$6.1 -$24.8 -$19.6 -$15.3 -$13.1 -$23.6 -$102.5 0.00% <-Total Growth 5 Net Income Growth 0.00% 0.00%
Cash Flow Growth $27.2 $32.7 $26.4 $9.3 $16.4 $16.9 $129.0 -37.64% <-Total Growth 5 Cash Flow Growth -37.64% -9.01%
Dividend Growth $0.20 $0.20 $0.20 $0.20 $0.80 0.00% <-Total Growth 3 Dividend Growth 0.00% 0.00%
Stock Price Growth $7.62 $11.63 $18.98 $13.84 $11.54 $7.25 -4.92% <-Total Growth 5 Stock Price Growth -4.92% -1.00%
Revenue Growth US$ $20.0 $54.0 $75.1 $61.4 $54.2 $56.1 $60.0 $61.5 $442.2 208.01% <-Total Growth 7 Revenue Growth US$ 208.01% 11.91%
EPS Growth -$0.92 -$0.60 -$0.24 -$0.92 -$0.67 -$0.48 -$0.41 -$0.73 -$4.97 0.00% <-Total Growth 7 EPS Growth 0.00% 0.00%
Net Income Growth -$9.6 -$14.9 -$6.1 -$24.8 -$19.6 -$15.3 -$13.1 -$23.6 -$127.0 0.00% <-Total Growth 7 Net Income Growth 0.00% 0.00%
Cash Flow Growth $21.8 $27.2 $32.7 $26.4 $9.3 $16.4 $16.9 $150.8 -22.13% <-Total Growth 6 Cash Flow Growth -22.13% -2.47%
Dividend Growth $0.20 $0.20 $0.20 $0.20 0.00% <-Total Growth 3 Dividend Growth 0.00% 0.00%
Stock Price Growth $8.28 $7.62 $7.62 $11.63 $18.98 $13.84 $11.54 $7.25 -12.44% <-Total Growth 7 Stock Price Growth -12.44% -1.32%
Dividends on Shares $0.00 $0.00 $4.40 $17.60 $17.60 $17.60 $17.60 $17.60 $17.60 $17.60 $74.80 No of Years 7 Total Divs 12/31/16
Paid  $1,008.99 $900.94 $841.76 $1,396.18 $2,169.31 $1,550.66 $1,287.48 $864.11 $392.02 $392.02 $1,482.95 $864.11 No of Years 7 Worth $11.47 87.22
Total $938.91
Assumed EPS $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01
Graham No. $1.61 $1.45 $1.42 $1.34 $1.29 $1.23 $1.19 $1.09 $1.06 $1.06 $2.48 -32.71% <-Total Growth 7 Graham Price CDN$
Price/GP Ratio Med 7.84 8.17 7.79 9.12 14.87 15.01 14.82 11.16 6.98 2.80 0.00 10.14 <-Median-> 8 Price/GP Ratio CDN$
Price/GP Ratio Hi 8.58 9.27 8.84 12.17 19.69 19.07 17.98 14.59 9.71 0.00 0.00 13.38 <-Median-> 8 Price/GP Ratio CDN$
Price/GP Ratio Low 7.10 7.07 6.74 6.07 10.05 10.95 11.66 7.73 4.24 0.00 0.00 7.42 <-Median-> 8 Price/GP Ratio CDN$
Price/GP Ratio Cl 7.10 7.07 6.74 10.97 19.69 14.58 12.62 9.05 4.00 4.00 6.80 10.01 <-Median-> 8 Price/GP Ratio CDN$
Prem /Disc. Close 610.12% 606.79% 573.99% 997.37% 1869.34% 1358.26% 1161.92% 804.81% 299.52% 299.52% 580.22% 901.09% <-Median-> 8 Graham Price CDN$
Close CDN$ re Exchange Rate $11.47 $10.24 $9.57 $15.87 $24.65 $17.62 $14.63 $9.82 $4.45 $4.45 $16.85 -4.09% <-Total Growth 7 Close CDN$ re Exchange Rate CDN$
Difference - amount $0.00 $0.00 $0.00 $1.22 -$0.85 -$0.38 -$0.37 -$0.01 $0.21 $0.21 $0.00 Differnce
Difference - percentage 0.00% 0.00% 0.00% -7.66% 3.44% 2.15% 2.53% 0.11% -4.82% -4.82% 0.00%
Price Close CDN$ $11.47 $10.24 $9.57 $14.65 $25.50 $18.00 $15.00 $9.83 $4.24 $4.24 $16.85 -14.27% <-Total Growth 7 Stock Price CDN$
Increase -10.71% -6.57% 53.15% 74.06% -29.41% -16.67% -34.47% -56.87% 0.00% 297.44% #NUM! <-Median-> 7 CAPE (10 Yr P/E) CDN$
P/E -9.00 -12.71 -31.77 -11.67 -29.30 -29.45 -28.86 -9.94 -6.48 -31.12 309.25 0.55% <-IRR #YR-> 5 Stock Price 2.77% CDN$
Trailing P/E -8.04 -11.87 -48.66 -20.32 -20.68 -24.54 -18.91 -4.29 -6.48 -123.70 -2.17% <-IRR #YR-> 7 Stock Price #DIV/0! CDN$
CAPE (10 Yr P/E) -16.28 -16.55 -21.05 2.29% <-IRR #YR-> 5 Price & Dividend 27.10%
Median 5 yrs D.  per yr 1.15% 1.74% % Tot Ret 0.00% 76.12% T P/E -20.32 -20.68 P/E:  -20.78 -28.86 -1.03% <-IRR #YR-> 7 Price & Dividend #DIV/0! CDN$
CAPE Diff #NUM!
-$9.57 $0.00 $0.00 $0.00 $0.00 $9.83
-$11.47 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $9.83
-$9.57 $0.05 $0.20 $0.20 $0.20 $10.03
-$11.47 $0.00 $0.00 $0.05 $0.20 $0.20 $0.20 $10.03
Price H/L Med. CDN$ $12.66 $11.83 $11.06 $12.18 $19.26 $18.53 $17.62 $12.13 $7.41 297.44% -4.20% <-Total Growth 7 Stock Price CDN$
Increase -6.51% -6.57% 10.13% 58.15% -3.77% -4.94% -31.17% -38.93% 4.72% -0.61% <-IRR #YR-> 7 Stock Price #DIV/0! CDN$
P/E -9.93 -14.69 -36.72 -9.70 -22.13 -30.32 -33.89 -12.26 -11.32 302.16% 1.86% <-IRR #YR-> 5 Stock Price 9.68% CDN$
Trailing P/E -9.29 -13.72 -40.44 -15.34 -21.29 -28.82 -23.33 -7.49 -0.38% <-IRR #YR-> 7 Price & Dividend CDN$
P/E on Running 5 yr Average -24.11 -24.76 -14.28 -10.16 2.29% <-IRR #YR-> 5 Price & Dividend CDN$
P/E on Running 10 yr Average -10.17 -18.41 P/E Ratio Historical Median CDN$
Median 10, 5 Yrs D.  per yr 0.23% 0.42% % Tot Ret -61.44% 18.54% T P/E -21.29 -23.33 P/E:  -18.41 -22.13 Count 8 Years of data
-$12.66 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $12.13
-$11.06 $0.00 $0.00 $0.00 $0.00 $12.13
-$12.66 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $12.33
-$11.06 $0.05 $0.00 $0.00 $0.00 $12.33
High Month Aug Nov Dec Jan Mar Mar Jan
Price High CDN$ $13.85 $13.43 $12.55 $16.25 $25.50 $23.54 $21.37 $15.85 $10.31 14.46% <-Total Growth 7 Stock Price CDN$
Increase -3.04% -6.57% 29.53% 56.92% -7.69% -9.22% -25.83% -34.95% 1.95% <-IRR #YR-> 7 Stock Price #DIV/0! CDN$
P/E -10.87 -16.67 -41.67 -12.95 -29.30 -38.52 -41.11 -16.03 -15.77 4.79% <-IRR #YR-> 5 Stock Price 26.35% CDN$
Trailing P/E -10.54 -15.57 -53.97 -20.32 -27.05 -34.97 -30.49 -10.43 -22.99 P/E Ratio Historical Median CDN$
Median 10, 5 Yrs T P/E -27.05 -30.49 P/E:  -22.99 -29.30 -15.11 P/E Ratio Historical High CDN$
-$13.85 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $15.85
-$12.55 $0.00 $0.00 $0.00 $0.00 $15.85
Low Month Jan Oct Sep Sep Jan Sep Dec Dec May
Price Low CDN$ $11.47 $10.24 $9.57 $8.10 $13.01 $13.52 $13.86 $8.40 $4.50 -26.74% <-Total Growth 7 Stock Price CDN$
Increase -10.71% -6.57% -15.32% 60.62% 3.92% 2.51% -39.39% -46.43% -4.35% <-IRR #YR-> 7 Stock Price #DIV/0! CDN$
P/E -9.00 -12.71 -31.77 -6.45 -14.95 -22.12 -26.66 -8.50 -6.88 -2.57% <-IRR #YR-> 5 Stock Price -12.18% CDN$
Trailing P/E -8.04 -11.87 -26.90 -10.37 -15.54 -22.68 -16.16 -4.55 -13.83 P/E Ratio Historical Median CDN$
Median 10, 5 Yrs T P/E -15.54 -16.16 P/E:  -13.83 -14.95 -23.49 P/E Ratio Historical Low CDN$
-$11.47 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $8.40
-$9.57 $0.00 $0.00 $0.00 $0.00 $8.40
Price Close CDN$ - US$ $8.28 $7.62 $7.62 $10.74 $19.63 $14.14 $11.83 $7.26 $3.11 $3.11 $12.37 -12.35% <-Total Growth 7
Price Close US$ $8.28 $7.62 $7.62 $11.63 $18.98 $13.84 $11.54 $7.25 $3.27 $3.27 $12.37 -12.44% <-Total Growth 7 Stock Price US$
Increase -7.91% 0.00% 52.53% 63.20% -27.08% -16.62% -37.18% -54.90% 0.00% 278.29% #NUM! <-Median-> 7 CAPE (10 Yr P/E)
P/E -9.00 -12.71 -31.77 -12.64 -28.33 -28.83 -28.15 -9.93 -6.81 -32.70 309.25 -1.00% <-IRR #YR-> 5 Stock Price -4.92% US$
Trailing P/E -8.29 -12.71 -48.46 -20.63 -20.66 -24.04 -17.68 -4.48 -6.81 -123.70 -1.88% <-IRR #YR-> 7 Stock Price #DIV/0! US$
CAPE (10 Yr P/E) -16.81 -21.22 0.74% <-IRR #YR-> 5 Price & Dividend -4.58% US$
Median 10, 5 Yrs D.  per yr 1.20% 1.74% % Tot Ret 0.00% 235.63% T P/E -20.63 -20.66 P/E:  -20.43 -28.15 -0.68% <-IRR #YR-> 7 Price & Dividend #DIV/0! US$
-$7.62 $0.00 $0.00 $0.00 $0.00 $7.25
-$8.28 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $7.25
-$7.62 $0.04 $0.15 $0.16 $0.16 $7.40
-$8.28 $0.00 $0.00 $0.04 $0.15 $0.16 $0.16 $7.40
Price H/L Med. US$ $9.14 $8.81 $8.81 $9.28 $15.32 $14.63 $13.70 $9.12 $5.48 -0.25% <-Total Growth 7 Stock Price US$
Increase -3.58% 0.00% 5.25% 65.18% -4.54% -6.36% -33.42% -39.90% -0.04% <-IRR #YR-> 7 Stock Price #DIV/0! US$
P/E -9.93 -14.69 -36.72 -10.08 -22.87 -30.47 -33.40 -12.49 -11.42 0.68% <-IRR #YR-> 5 Stock Price 3.46% US$
Trailing P/E -9.58 -14.69 -38.65 -16.65 -21.83 -28.53 -22.24 -7.51 0.97% <-IRR #YR-> 7 Price & Dividend US$
P/E on Running 5 yr Average -25.13 -25.17 -14.20 -9.89 2.13% <-IRR #YR-> 5 Price & Dividend US$
P/E on Running 10 yr Average -11.42 -18.78 P/E Ratio Historical Median
Median 10, 5 Yrs D.  per yr 1.01% 1.45% % Tot Ret 103.61% 68.01% T P/E -21.83 -22.24 P/E:  -18.78 -22.87
-$9.14 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $9.12
-$8.81 $0.00 $0.00 $0.00 $0.00 $9.12
-$9.14 $0.00 $0.00 $0.04 $0.15 $0.16 $0.16 $9.27
-$8.81 $0.04 $0.15 $0.16 $0.16 $9.27
High Month Nov Dec Jan Apr Feb Jan
Price High US$ $10.00 $10.00 $10.00 $12.21 $19.89 $19.10 $16.99 $12.00 $7.67 20.00% <-Total Growth 7 Stock Price US$
Increase 0.00% 0.00% 22.10% 62.90% -3.97% -11.05% -29.37% -36.08% 2.64% <-IRR #YR-> 7 Stock Price #DIV/0! US$
P/E -10.87 -16.67 -41.67 -13.27 -29.69 -39.79 -41.44 -16.44 -15.98 3.71% <-IRR #YR-> 5 Stock Price 20.00% US$
Trailing P/E -10.87 -16.67 -50.88 -21.62 -28.51 -35.40 -29.27 -10.51 -23.18 P/E Ratio Historical Median US$
Median 10, 5 Yrs T P/E -28.51 -29.27 P/E:  -23.18 -29.69 -15.49 P/E Ratio Historical High US$
-$10.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $12.00
-$10.00 $0.00 $0.00 $0.00 $0.00 $12.00
Low Month Feb Sep Dec Nov May
Price Low US$ $8.28 $7.62 $7.62 $6.34 $10.75 $10.15 $10.40 $6.24 $3.29 -24.70% <-Total Growth 7 Stock Price US$
Increase -7.91% 0.00% -16.85% 69.56% -5.58% 2.46% -40.05% -47.23% -3.97% <-IRR #YR-> 7 Stock Price #DIV/0! US$
P/E -9.00 -12.71 -31.77 -6.89 -16.04 -21.15 -25.37 -8.54 -6.85 -3.94% <-IRR #YR-> 5 Stock Price -18.23% US$
Trailing P/E -8.29 -12.71 -26.42 -11.68 -15.15 -21.67 -15.21 -4.51 -14.38 P/E Ratio Historical Median US$
Median 10, 5 Yrs T P/E -15.15 -15.21 P/E:  -14.38 -16.04 -22.41 P/E Ratio Historical Low US$
-$8.28 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $6.24
-$7.62 $0.00 $0.00 $0.00 $0.00 $6.24
Free Cash Flow WSJ CDN$ $28.41 $35.03 $27.47 $33.45 $12.48 $20.54 $22.00 $24.5 $47.7 $66.1 -22.56% <-Total Growth 6 Free Cash Flow
Change 23.32% -21.57% 21.76% -62.68% 64.51% 7.10% 11.47% 94.44% 38.57% 14.43% <-Median-> 6 Change
Free Cash Flow MS -$2.94 $21.48 $26.43 $31.97 $23.85 -$35.33 $11.92 $6.79 $18.0 $35.0 $48.5 330.95% <-Total Growth 7 Free Cash Flow US$
Change 830.61% 23.04% 20.96% -25.40% -248.13% 133.74% -43.04% 165.10% 94.44% 38.57% -23.80% <-IRR #YR-> 5 Free Cash Flow MS -74.31% US$
FCF/CF from Op Ratio 0.99 0.97 0.98 0.90 -3.78 0.73 0.40 1.18 #VALUE! #DIV/0! #NUM! <-IRR #YR-> 7 Free Cash Flow MS #DIV/0! US$
Dividends paid $1.05 $4.33 $4.75 $4.75 $4.75 $4.75 $4.75 $4.75 9.63% <-Total Growth 4 Dividends paid US$
Percentage paid 0.00% 0.00% 0.00% 3.27% 18.16% -13.44% 39.84% 69.94% 26.39% 13.57% 9.79% $0.02 <-Median-> 8 Percentage paid US$
5 Year Coverage 5.34% 14.81% 25.28% 50.07% 92.47% 65.28% 19.76% 5 Year Coverage US$
Dividend Coverage Ratio 0.00 0.00 0.00 30.53 5.51 -7.44 2.51 1.43 3.79 7.37 10.21 0.71 <-Median-> 8 Dividend Coverage Ratio US$
5 Year of Coverage 18.74 6.75 3.96 2.00 1.08 1.53 5.06 5 Year of Coverage US$
Market Cap US$ $192.743 $192.743 $192.743 $317.444 $589.502 $440.422 $374.487 $234.578 $105.803 $105.803 $400.239 21.71% <-Total Growth 7 Market Cap  US$
Market Cap CDN$ $266.900 $258.796 $241.796 $399.876 $792.008 $572.803 $486.768 $318.056 $137.188 $137.188 $545.246 19.17% <-Total Growth 7 Market Cap  CDN$
Diluted # of Shares in Million 23.278 24.775 25.278 26.953 29.308 31.714 32.184 32.433 31.893 39.33% <-Total Growth 7 Diluted
Change 6.43% 2.03% 6.62% 8.74% 8.21% 1.48% 0.77% -1.66% 6.43% <-Median-> 7 Change
Difference Diluted/Basic 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% <-Median-> 8 Difference Diluted/Basic
Basic # of Shares in Millions 23.278 24.775 25.278 26.953 29.308 31.714 32.184 32.433 31.893 39.33% <-Total Growth 7 Basic
Change 6.43% 2.03% 6.62% 8.74% 8.21% 1.48% 0.77% -1.66% 6.43% <-Median-> 7 Change
Difference Basic/Outstanding 0.00% 2.03% 0.00% 1.27% 5.97% 0.34% 0.83% -0.24% 1.45% 0.59% <-Median-> 8 Difference Basic/Outstanding
$15.204 <-12 mths -10.26%
# of Shares in Millions 23.278 25.278 25.278 27.295 31.059 31.822 32.451 32.356 32.356 32.356 32.356 5.06% <-IRR #YR-> 5 Shares #DIV/0!
Change 8.59% 0.00% 7.98% 13.79% 2.46% 1.98% -0.29% 0.00% 0.00% 0.00% 5.06% <-IRR #YR-> 5 Shares 28.00%
CF fr Op $M US$ $21.758 $27.166 $32.747 $26.408 $9.344 $16.429 $16.942 $15.204 <-12 mths -22.13% <-Total Growth 6 Cash Flow US$
Increase 24.86% 20.54% -19.36% -64.62% 75.82% 3.12% -10.26% <-12 mths SO Buy Back, DRIP S Iss
5 year Running Average $23 $22 $20 $17 <-12 mths -13.25% <-Total Growth 2 CF 5 Yr Running US$
CFPS US$ $0.86 $1.07 $1.20 $0.85 $0.29 $0.51 $0.52 $0.47 <-12 mths -39.17% <-Total Growth 6 Cash Flow per Share US$
Increase 24.86% 11.64% -29.13% -65.47% 72.42% 3.43% -10.26% <-12 mths -4.08% <-IRR #YR-> 6 Cash Flow #DIV/0! US$
5 year Running Average $0.86 $0.78 $0.67 $0.53 <-12 mths -9.01% <-IRR #YR-> 5 Cash Flow -37.64% US$
P/CF on Med Price 10.24 8.20 7.73 18.02 49.81 27.05 17.41 11.66 <-12 mths -7.95% <-IRR #YR-> 6 Cash Flow per Share #DIV/0! US$
P/CF on Closing Price 8.86 7.10 9.69 22.32 47.13 22.79 13.85 6.96 <-12 mths -13.39% <-IRR #YR-> 5 Cash Flow per Share -51.28% US$
-60.04% Diff M/C -11.21% <-IRR #YR-> 2 CFPS 5 yr Running #DIV/0! US$
$12.67 <-12 mths -17.67%
Excl.Working Capital CF -$7.265 $8.443 -$6.455 -$1.549 $7.665 $2.313 -$1.547 $12.674 <-12 mths -11.21% <-IRR #YR-> 2 CFPS 5 yr Running #DIV/0! US$
CF fr Op $M WC US$ $14.493 $35.609 $26.292 $24.859 $17.009 $18.742 $15.395 $12.674 <-12 mths 6.22% <-Total Growth 6 Cash Flow less WC US$
Increase 145.70% -26.16% -5.45% -31.58% 10.19% -17.86% -17.67% <-12 mths 1.01% <-IRR #YR-> 6 Cash Flow less WC #DIV/0! US$
5 year Running Average $24 $25 $20 $18 <-12 mths -15.44% <-IRR #YR-> 5 Cash Flow less WC -56.77% US$
CFPS Excl. WC US$ $0.57 $1.41 $0.96 $0.80 $0.53 $0.58 $0.48 $0.39 <-12 mths -6.99% <-IRR #YR-> 2 CF less WC 5 Yr Run #DIV/0! US$
Increase 145.70% -31.62% -16.91% -33.22% 8.05% -17.62% -17.67% <-12 mths -6.99% <-IRR #YR-> 2 CF less WC 5 Yr Run #DIV/0! US$
5 year Running Average $0.86 $0.86 $0.67 $0.56 <-12 mths -3.06% <-IRR #YR-> 6 CFPS - Less WC #DIV/0! US$
P/CF on Med Price 15.37 6.26 9.63 19.14 27.36 23.71 19.16 13.99 <-12 mths -19.51% <-IRR #YR-> 5 CFPS - Less WC -66.22% US$
P/CF on Closing Price 13.30 5.41 12.07 23.71 25.89 19.98 15.24 8.35 <-12 mths -11.51% <-IRR #YR-> 2 CFPS 5 yr Running #DIV/0! US$
CF/-WC P/CF Med 10 yr 17.41 5 yr  18.02 P/CF Med 10 yr 19.14 5 yr  19.16 -56.39% Diff M/C -11.51% <-IRR #YR-> 2 CFPS 5 yr Running #DIV/0! US$
$20.712 <-12 mths -9.74%
CF fr Op $M CDN$ $29.214 $34.080 $44.673 $34.299 $11.897 $20.829 $22.946 $20.712 <-12 mths -21.46% <-Total Growth 6 Cash Flow CDN$
Increase 16.65% 31.09% -23.22% -65.31% 75.08% 10.17% -9.74% <-12 mths SO Buy Back, DRIP S Iss
5 year Running Average $31 $29 $27 $22 <-12 mths -12.66% <-Total Growth 2 CF 5 Yr Running CDN$
CFPS CDN$ $1.16 $1.35 $1.64 $1.10 $0.37 $0.64 $0.71 $0.64 <-12 mths -38.64% <-Total Growth 6 Cash Flow per Share CDN$
Increase 16.65% 21.40% -32.53% -66.15% 71.69% 10.49% -9.74% <-12 mths -3.95% <-IRR #YR-> 6 Cash Flow #DIV/0! CDN$
5 year Running Average $1.12 $1.02 $0.89 $0.69 <-12 mths -7.61% <-IRR #YR-> 5 Cash Flow -32.67% CDN$
P/CF on Med Price 10.24 8.20 7.44 17.44 49.57 27.44 17.10 11.57 <-12 mths -7.82% <-IRR #YR-> 6 Cash Flow per Share #DIV/0! CDN$
P/CF on Closing Price 8.86 7.10 8.95 23.09 48.15 23.37 13.86 6.62 <-12 mths -12.06% <-IRR #YR-> 5 Cash Flow per Share -47.40% CDN$
-61.26% Diff M/C -10.85% <-IRR #YR-> 2 CFPS 5 yr Running #DIV/0! CDN$
$17.27 <-12 mths -17.19%
Excl.Working Capital CF -$9.755 $10.592 -$8.806 -$2.012 $9.759 $2.932 -$2.095 $17.266 <-12 mths -10.85% <-IRR #YR-> 2 CFPS 5 yr Running #DIV/0! CDN$
CF fr Op $M WC CDN$ $19.460 $44.671 $35.868 $32.287 $21.656 $23.761 $20.851 $17.266 <-12 mths 7.15% <-Total Growth 6 Cash Flow less WC CDN$
Increase 129.56% -19.71% -9.98% -32.93% 9.72% -12.25% -17.19% <-12 mths 1.16% <-IRR #YR-> 6 Cash Flow less WC #DIV/0! CDN$
5 year Running Average $31 $32 $27 $23 <-12 mths -14.13% <-IRR #YR-> 5 Cash Flow less WC -53.32% CDN$
CFPS Excl. WC CDN$ $0.77 $1.77 $1.31 $1.04 $0.68 $0.73 $0.64 $0.53 <-12 mths -6.55% <-IRR #YR-> 2 CF less WC 5 Yr Run #DIV/0! CDN$
Increase 129.56% -25.64% -20.89% -34.54% 7.60% -11.99% -17.19% <-12 mths -6.55% <-IRR #YR-> 2 CF less WC 5 Yr Run #DIV/0! CDN$
5 year Running Average $1.11 $1.11 $0.88 $0.73 <-12 mths -2.92% <-IRR #YR-> 6 CFPS - Less WC #DIV/0! CDN$
P/CF on Med Price 15.37 6.26 9.27 18.52 27.23 24.06 18.82 13.88 <-12 mths -18.27% <-IRR #YR-> 5 CFPS - Less WC -63.53% CDN$
P/CF on Closing Price 13.30 5.41 11.15 24.53 26.45 20.49 15.25 7.95 <-12 mths -11.02% <-IRR #YR-> 2 5 yr Running #DIV/0! CDN$
*Operational Cash Flow per share  CF/-WC P/CF Med 10 yr 17.10 5 yr  17.44 P/CF Med 10 yr 18.52 5 yr  18.82 -57.10% Diff M/C -11.02% <-IRR #YR-> 2 5 yr Running #DIV/0! CDN$
G&M used Changed in WC and other items.
-$1.35 $0.00 $0.00 $0.00 $0.00 $0.71 Cash Flow per Share CDN$
-$1.12 $0.00 $0.89 CFPS 5 yr Running CDN$
-$1.12 $0.00 $0.89 CFPS 5 yr Running CDN$
-$19 $0.00 $0.00 $0.00 $0.00 $0.00 $21 Cash Flow less WC CDN$
-$45 $0.00 $0.00 $0.00 $0.00 $21 Cash Flow less WC CDN$
-$31 $0 $27 CF less WC 5 Yr Run CDN$
-$31 $0 $27 CF less WC 5 Yr Run CDN$
OPM 40.27% 36.18% 53.32% 48.76% 16.65% 27.38% 27.56% 23.04% -31.55% <-Total Growth 6 OPM
Increase -10.15% 47.37% -8.56% -65.85% 64.40% 0.68% -16.42% Should increase  or be stable.
Diff from Median 11.3% 0.0% 47.4% 34.8% -54.0% -24.3% -23.8% -36.3% 0.00 <-Median-> 7 OPM CDN$
*Operational Profit Margin (CF/Revenue) Ratio OPM 10 Yrs 36.18% 5 Yrs 27.56% should be  zero, it is a   check on calculations
Long Term Debt US$ $166.499 $173.265 $158.114 $104.459 $91.822 $99.015 $86.844 $84.578 $84.408 -49.20% <-Total Growth 7 Debt US$
Change 4.06% -8.74% -33.93% -12.10% 7.83% -12.29% -2.61% -0.20% -8.74% <-Median-> 7 Change US$
Debt/Market Cap Ratio 0.86 0.90 0.82 0.33 0.16 0.22 0.23 0.36 0.80 0.34 <-Median-> 8 Debt/Market Cap Ratio
Assets/Current Liabilities Ratio 17.40 14.48 11.12 8.01 6.78 8.53 9.97 7.75 7.70 9.25 <-Median-> 8 Assets/Current Liabilities Ratio
Debt to Cash Flow (Years) 7.96 5.82 3.19 3.48 10.60 5.29 4.99 5.55 5.29 <-Median-> 7 Debt to Cash Flow (Years)
Intangibles US$ $306.014 $327.983 $312.659 $271.153 $252.050 $253.404 $229.181 $195.018 $186.957 -36.27% <-Total Growth 7 Intangibles US$
Goodwill $8.299 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 -100.00% <-Total Growth 7 Goodwill US$
Total $314.313 $327.983 $312.659 $271.153 $252.050 $253.404 $229.181 $195.018 $186.957 -37.95% <-Total Growth 7 Total US$
Change 4.35% -4.67% -13.28% -7.05% 0.54% -9.56% -14.91% -4.13% -7.05% <-Median-> 7 Change US$
Intangible/Market Cap Ratio 1.63 1.70 1.62 0.85 0.43 0.58 0.61 0.83 1.77 0.84 <-Median-> 8 Intangible/Market Cap Ratio
Current Assets US$ $57.112 $54.072 $65.036 $31.618 $63.100 $45.911 $43.751 $44.374 $45.043 -22.30% <-Total Growth 7 Current Assets US$
Current Liabilities $22.035 $26.568 $34.602 $38.268 $47.139 $35.642 $27.672 $31.190 $30.398 41.55% <-Total Growth 7 Current Liabilities US$
Liquidity 2.59 2.04 1.88 0.83 1.34 1.29 1.58 1.42 1.48 1.50 <-Median-> 8 Ratio US$
Liq. with CF aft div 2.59 2.85 2.66 1.66 1.80 1.41 1.99 1.81 1.83 1.80 <-Median-> 5 Ratio US$
Liq. CF re  Inv+Div  2.59 1.64 2.04 1.30 1.36 0.63 1.71 1.37 1.83 1.36 <-Median-> 5 Ratio US$
Assets US$ $383.308 $384.628 $384.646 $306.425 $319.671 $303.906 $275.905 $241.652 $234.155 -36.96% <-Total Growth 7 Assets US$
Liabilities $188.534 $209.064 $204.264 $147.936 $141.472 $134.657 $115.169 $116.334 $115.264 -38.30% <-Total Growth 7 Liabilities US$
Debt Ratio 2.03 1.84 1.88 2.07 2.26 2.26 2.40 2.08 2.03 2.07 <-Median-> 8 Ratio Same in US$ US$
Check $194.774 $175.564 $180.382 $158.489 $178.199 $169.249 $160.736 $125.318 $118.891 US$
Estimates BVPS $3.32 $3.20 Estimates Estimates BVPS
Estimate Book Value $107.4 $103.5 Estimates Estimate Book Value
P/B Ratio (Close) 0.98 1.02 Estimates P/B Ratio (Close)
Difference from 10 year median -50.15% Diff M/C Estimates Difference from 10 yr med.
Total Book Value US$ $194.774 $175.564 $180.382 $158.489 $178.199 $169.249 $160.736 $125.318 $118.891 $118.891 $118.891 -35.66% <-Total Growth 7 Book Value US$
Preference Shares  US$ $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 #DIV/0! <-Total Growth 7 Preference Shares US$
Net Book Value US$ $194.774 $175.564 $180.382 $158.489 $178.199 $169.249 $160.736 $125.318 $118.891 $118.891 $118.891 -35.66% <-Total Growth 7 Book Value US$
Book Value per Share $8.37 $6.95 $7.14 $5.81 $5.74 $5.32 $4.95 $3.87 $3.67 $3.67 $3.67 -53.71% <-Total Growth 7 Book Value per Share US$
Change -16.99% 2.74% -18.63% -1.19% -7.30% -6.87% -21.80% -5.13% 0.00% 0.00% -54.96% P/B Ratio Current/Historical Median US$
P/B Ratio (Median) 1.09 1.27 1.23 1.60 2.67 2.75 2.76 2.35 1.49 1.98 P/B Ratio Historical Median US$
P/B Ratio (Close) 0.99 1.10 1.07 2.00 3.31 2.60 2.33 1.87 0.89 0.89 3.37 -10.42% <-IRR #YR-> 7 Book Value per Share #DIV/0! US$
Change 10.94% -2.67% 87.45% 65.16% -21.34% -10.47% -19.66% -52.46% 0.00% 278.29% -11.50% <-IRR #YR-> 5 Book Value per Share -45.72% US$
Leverage (A/BK) 1.97 2.19 2.13 1.93 1.79 1.80 1.72 1.93 1.97 0.00 0.00 1.93 <-Median-> 7 A/BV US$
Debt/Equity Ratio 0.97 1.19 1.13 0.93 0.79 0.80 0.72 0.93 0.97 0.00 0.00 0.93 <-Median-> 7 Debt/Eq Ratio US$
Book Value is Asset less Liabilities P/BV 10 yr Med 1.98 5 yr Med 2.67 -54.96% Diff M/C 1.93 Historical 8 A/BV US$
Long Term Debt CDN$ $230.558 $232.643 $198.354 $142.503 $119.258 $126.066 $110.101 $114.552 $114.989 -50.32% <-Total Growth 7 Debt CDN$
Change 0.90% -14.74% -28.16% -16.31% 5.71% -12.66% 4.04% 0.38% -12.66% <-Median-> 7 Change CDN$
Debt/Market Cap Ratio 0.86 0.90 0.82 0.36 0.15 0.22 0.23 0.36 0.84 0.36 <-Median-> 7 Debt/Market Cap Ratio CDN$
Assets/Current Liabilities Ratio 17.40 14.48 11.12 8.01 6.78 8.53 9.97 7.75 7.70 9.25 <-Median-> 8 Assets/Current Liabilities Ratio
Debt to Cash Flow (Years) 7.96 5.82 3.19 3.48 10.60 5.29 4.99 5.55 5.29 <-Median-> 7 Debt to Cash Flow (Years)
Intangibles CDN$ $423.751 $440.383 $392.231 $369.907 $327.363 $322.634 $290.556 $264.132 $264.132 -37.67% <-Total Growth 7 Intangibles CDN$
Goodwill $11.492 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 -100.00% <-Total Growth 7 Goodwill CDN$
Total $435.243 $440.383 $392.231 $369.907 $327.363 $322.634 $290.556 $264.132 $254.692 -39.31% <-Total Growth 7 Total CDN$
Change 1.18% -10.93% -5.69% -11.50% -1.44% -9.94% -9.09% -3.57% -9.09% <-Median-> 7 Change CDN$
Intangible/Market Cap Ratio 1.63 1.70 1.62 0.93 0.41 0.56 0.60 0.83 1.86 0.88 <-Median-> 7 Intangible/Market Cap Ratio CDN$
Current Assets CDN$ $79.085 $72.602 $81.588 $43.133 $81.954 $58.454 $55.468 $60.100 $61.362 -24.01% <-Total Growth 7 Assets CDN$
Current Liabilities $30.513 $35.673 $43.408 $52.205 $61.224 $45.379 $35.083 $42.244 $41.411 38.45% <-Total Growth 7 Liabilities CDN$
Liquidity 2.59 2.04 1.88 0.83 1.34 1.29 1.58 1.42 1.48 1.50 <-Median-> 8 Ratio Same in US$ CDN$
Liq. with CF aft div 2.59 2.85 2.66 1.66 1.80 1.41 1.99 1.81 1.83 Uses actual CDN dividends received Same in US$ CDN$
Liq. CF re  Inv+Div  2.59 1.64 2.04 1.30 1.36 0.63 1.71 1.37 1.83 US$ one above more accurate Same in US$ CDN$
Curr Long Term Debt $0 $0 $0 $0 $0 $0 $0 $13.740 Same in US$ CDN$
Assets CDN$ $530.783 $516.440 $482.538 $418.025 $415.189 $386.933 $349.792 $327.293 $318.989 -38.34% <-Total Growth 7 Assets CDN$
Liabilities $261.071 $280.710 $256.249 $201.814 $183.744 $171.445 $146.011 $157.563 $157.024 -39.65% <-Total Growth 7 Liabilities CDN$
Debt Ratio 2.03 1.84 1.88 2.07 2.26 2.26 2.40 2.08 2.03 2.07 <-Median-> 8 Ratio CDN$
Check  $270 $236 $226 $216 $231 $215 $204 $170 $162
Estimates BVPS $4.52 $4.36 Estimates Estimates BVPS
Estimate Book Value $146.3 $141.0 Estimates Estimate Book Value
P/B Ratio (Close) 0.94 0.97 Estimates P/B Ratio (Close)
Difference from 10 year median -51.28% Diff M/C Estimates Difference from 10 yr med.
Book Value Check $269.712 $235.730 $226.289 $216.211 $231.445 $215.488 $203.781 $169.731 $161.965
Total Book Value CDN$ $269.712 $235.730 $226.289 $216.211 $231.445 $215.488 $203.781 $169.731 $161.965 $161.965 $161.965 -37.07% <-Total Growth 7 Book Value CDN$
Preference Shares  CDN$ $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 $0.000 #DIV/0! <-Total Growth 7
Net Book Value CDN$ $269.712 $235.730 $226.289 $216.211 $231.445 $215.488 $203.781 $169.731 $161.965 $161.965 $161.965 -37.07% <-Total Growth 7 Book Value CDN$
Book Value per Share $11.59 $9.33 $8.95 $7.92 $7.45 $6.77 $6.28 $5.25 $5.01 $5.01 $5.01 -54.73% <-Total Growth 7 Book Value per Share CDN$
Change -19.51% -4.00% -11.52% -5.93% -9.13% -7.27% -16.46% -4.58% 0.00% 0.00% -55.98% P/B Ratio Current/Historical Median CDN$
P/B Ratio (Median) 1.09 1.27 1.23 1.54 2.58 2.74 2.81 2.31 1.48 1.92 P/B Ratio Historical Median CDN$
P/B Ratio (Close) 0.99 1.10 1.07 1.85 3.42 2.66 2.39 1.87 0.85 0.85 3.37 -10.70% <-IRR #YR-> 7 Book Value per Share #DIV/0! CDN$
Change 10.94% -2.67% 73.09% 85.03% -22.32% -10.14% -21.55% -54.80% 0.00% 297.44% -10.14% <-IRR #YR-> 5 Book Value per Share -41.40% CDN$
Leverage (A/BK) 1.97 2.19 2.13 1.93 1.79 1.80 1.72 1.93 1.97 1.93 <-Median-> 7 A/BV CDN$
Debt/Equity Ratio 0.97 1.19 1.13 0.93 0.79 0.80 0.72 0.93 0.97 0.93 <-Median-> 7 Debt/Eq Ratio CDN$
Median Values P/BV 10 yr Med 1.92 5 yr Med 2.58 -55.98% 1.93 Historical 8 A/BV
-$36.338 <-12 mths 14.21%
Comprehensive Income  US$ -$19.504 $4.455 -$38.202 -$12.634 -$12.774 -$12.178 -$31.817 -63.13% <-Total Growth 6 Comprehensive Income US$
Increase 122.84% -957.51% 66.93% -1.11% 4.67% -161.27% -1.1% <-Median-> 5 Comprehensive Income US$
5 Yr Running Average -$4 -$3 -$11 -$13 -$16 -$14 -$22 8.50% <-IRR #YR-> 6 Comprehensive Income #DIV/0! US$
ROE US$ -11.1% 2.5% -24.1% -7.1% -7.5% -7.6% -25.4% #NUM! <-IRR #YR-> 5 Comprehensive Income -151.84% US$
5Yr Median -9.1% -7.5% -7.5% -7.6% 17.76% <-IRR #YR-> 3 5 Yr Running Average #DIV/0! US$
% Difference from NI 31.0% -173.1% 54.0% -35.4% -16.7% -7.2% 34.8% 17.76% <-IRR #YR-> 3 5 Yr Running Average -615.03% US$
Median Values Diff 5, 10 yr -7.2% -7.2% -7.6% <-Median-> 5 Return on Equity US$
Current Liability Coverage Ratio US$ 0.55 1.03 0.69 0.53 0.48 0.68 0.49 0.42   CFO / Current Liabilities US$
5 year Median 0.55 0.79 0.69 0.62 0.55 0.68 0.53 0.49 0.53 <-Median-> 5 Current Liability Cov Ratio US$
Asset Efficiency Ratio US$ 3.77% 9.26% 8.58% 7.78% 5.60% 6.79% 6.37% 5.41% CFO / Total Assets US$
5 year Median 3.77% 6.51% 8.58% 8.18% 7.78% 7.78% 6.79% 6.37% 6.8% <-Median-> 5 Return on Assets  US$
Return on Assets ROA US$ -2.5% -3.9% -1.6% -8.1% -6.1% -5.0% -4.8% -9.8% 31.9% Net  Income/Assets Return on Assets US$
5Yr Median -2.5% -3.2% -2.5% -3.2% -3.9% -5.0% -5.0% -6.1% -5.0% -6.1% <-Median-> 5 Asset Efficiency Ratio US$
Return on Equity ROE US$ -4.9% -8.5% -3.4% -15.7% -11.0% -9.1% -8.2% -18.8% 62.8% Net Inc/ Shareholders' equity Return on Equity US$
5Yr Median -4.9% -6.7% -4.9% -6.7% -8.5% -9.1% -9.1% -11.0% -9.1% -11.0% <-Median-> 5 Return on Equity US$
-$25.774 <-12 mths 9.22%
Net Income US$ -$9.638 -$14.893 -$6.097 -$24.806 -$19.552 -$15.331 -$13.117 -$23.598 $74.7 $74.7 -144.84% <-Total Growth 7 Net Income US$
Increase -54.52% 59.06% -306.86% 21.18% 21.59% 14.44% -79.90% 416.55% 0.00% EPS/CF Ratio should not be higher than 1.00 US$
5 Yr Running Average -$14.997 -$16.136 -$15.781 -$19.281 $0.620 $19.471 13.65% <-IRR #YR-> 7 Net Income #DIV/0! US$
Operating Cash Flow $21.758 $27.166 $32.747 $26.408 $9.344 $16.429 $16.942 31.08% <-IRR #YR-> 5 Net Income 4.87% US$
Investment Cash Flow -$19.693 -$10.533 -$10.533 -$15.359 -$44.677 -$4.510 -$10.148 8.74% <-IRR #YR-> 3 5 Yr Running Ave. #DIV/0! US$
Total Accrual -$16.958 -$22.730 -$47.020 -$30.601 $20.002 -$25.036 -$30.392 8.74% <-IRR #YR-> 3 5 Yr Running Ave. #DIV/0! US$
Total Assets $384.628 $384.646 $306.425 $319.671 $303.906 $275.905 $241.652 Balance Sheet Assets US$
Accruals Ratio -4.41% -5.91% -15.34% -9.57% 6.58% -9.07% -12.58% -9.57% <-Median-> 5 Ratio US$
EPS/CF Ratio -1.05 -0.17 -0.96 -0.84 -0.90 -0.71 -1.53 -0.90 <-Median-> 7 EPS/CF Ratio US$
Chge in Close US$ -7.91% 0.00% 52.53% 63.20% -27.08% -16.62% -37.18% -54.90% 0.00% 278.29% Count 8 Years of data US$
up/down up up up down up up Count 6 75.00% US$
Meet Prediction? Yes Yes Yes % right Count 3 50.00% US$
Financial Cash Flow US$ -$21.738 -$18.210 -$42.856 $23.947 $9.564 -$11.398 -$6.856 C F Statement  Financial Cash Flow US$
Total Accruals $4.780 -$4.520 -$4.164 -$54.548 $10.438 -$13.638 -$23.536 Accruals US$
Accruals Ratio 1.24% -1.18% -1.36% -17.06% 3.43% -4.94% -9.74% -4.94% <-Median-> 5 Ratio US$
Cash US$ $57.112 $37.763 $36.219 $10.930 $47.078 $20.612 $21.179 $20.723 $21.214 Cash US$
Cash per Share $2.45 $1.49 $1.43 $0.40 $1.52 $0.65 $0.65 $0.64 $0.66 $0.65 <-Median-> 5 Cash per Share US$
Percentage of Stock Price 29.63% 19.59% 18.79% 3.44% 7.99% 4.68% 5.66% 8.83% 20.05% 5.66% <-Median-> 5 % of Stock Price
-$49.22 <-12 mths 22.01%
Comprehensive Income CDN$ -$27.008 $5.982 -$47.924 -$17.235 -$16.591 -$15.505 -$40.338 -49.35% <-Total Growth 6 Comprehensive Income CDN$
Increase 122.15% -901.18% 64.04% 3.74% 6.54% -160.16% 3.7% <-Median-> 5 Comprehensive Income CDN$
5 Yr Running Average -$17 -$21 -$18 -$28 6.91% <-IRR #YR-> 6 Comprehensive Income #DIV/0! CDN$
ROE CDN$ -11.5% 2.6% -22.2% -7.4% -7.7% -7.6% -23.8% #NUM! <-IRR #YR-> 5 Comprehensive Income -774.35% CDN$
5Yr Median -11.5% -9.5% -7.7% -7.6% -7.7% 16.87% <-IRR #YR-> 3 5 Yr Running Average #DIV/0! CDN$
% Difference from NI 35.1% -178.2% 41.6% -32.1% -15.0% -6.8% 26.2% 16.87% <-IRR #YR-> 3 5 Yr Running Average #DIV/0! CDN$
Median Values Diff 5, 10 yr -15.0% -15.0% -7.7% <-Median-> 5 Return on Equity CDN$
Current Liability Coverage Ratio CDN$ 0.55 1.03 0.69 0.53 0.48 0.68 0.49 0.42   CFO / Current Liabilities CDN$
5 year Median 0.55 0.79 0.69 0.62 0.55 0.68 0.53 0.49 0.53 <-Median-> 5 Current Liability Cov Ratio CDN$
Asset Efficiency Ratio CDN$ 3.77% 9.26% 8.58% 7.78% 5.60% 6.79% 6.37% 5.41% CFO / Total Assets CDN$
5 year Median 3.77% 6.51% 8.58% 8.18% 7.78% 7.78% 6.79% 6.37% 6.8% <-Median-> 5 Return on Assets  CDN$
Return on Assets ROA CDN$ -2.51% -3.87% -1.59% -8.10% -6.12% -5.04% -4.75% -9.77% -6.36% Net  Income/Assets Return on Assets CDN$
5Yr Median -2.51% -3.19% -2.51% -3.19% -3.87% -5.04% -5.04% -6.12% -6.12% -6.1% <-Median-> 5 Asset Efficiency Ratio CDN$
Return on Equity ROE CDN$ -4.95% -8.48% -3.38% -15.65% -10.97% -9.06% -8.16% -18.83% -12.53% Net Inc/ Shareholders' equity Return on Equity CDN$
5Yr Median -4.95% -6.72% -4.95% -6.72% -8.48% -9.06% -9.06% -10.97% -10.97% -11.0% <-Median-> 5 Return on Equity CDN$
-$34.91 <-12 mths 9.22%
Net Income CDN$ -$13.346 -$19.997 -$7.649 -$33.840 -$25.394 -$19.519 -$16.630 -$31.961 -$20.3 -$12.0 $1.3 -139.48% <-Total Growth 7 Net Income CDN$
Increase -49.83% 61.75% -342.43% 24.96% 23.13% 14.80% -92.19% 36.49% 40.89% 110.83% EPS/CF Ratio should not be higher than 1.00 CDN$
5 Yr Running Average -$20.045 -$21.280 -$20.606 -$25.469 -$22.761 -$20.082 -$15.918 13.29% <-IRR #YR-> 7 Net Income #DIV/0! CDN$
Operating Cash Flow $29.214 $36.476 $41.081 $36.026 $12.136 $20.917 $21.479 33.11% <-IRR #YR-> 5 Net Income -317.86% CDN$
Investment Cash Flow -$26.442 -$13.214 -$14.369 -$19.948 -$56.883 -$5.718 -$13.744 8.31% <-IRR #YR-> 3 5 Yr Running Ave. #DIV/0! CDN$
Total Accrual -$22.770 -$30.911 -$60.552 -$41.472 $25.227 -$31.829 -$39.696 8.31% <-IRR #YR-> 3 5 Yr Running Ave. #DIV/0! CDN$
Total Assets $516.440 $482.538 $418.025 $415.189 $386.933 $349.792 $327.293 Balance Sheet Assets CDN$
Accruals Ratio -4.41% -6.41% -14.49% -9.99% 6.52% -9.10% -12.13% -9.99% <-Median-> 5 Ratio CDN$
EPS/CF Ratio -1.05 -0.17 -0.96 -0.84 -0.90 -0.71 -1.53 -0.90 <-Median-> 7 EPS/CF Ratio CDN$
Change in Close 0.00% -10.71% -6.57% 53.15% 74.06% -29.41% -16.67% -34.47% -56.87% 0.00% 297.44% Count 9 Years of data CDN$
up/down up up up down up up Count 6 66.67% CDN$
Meet Prediction? Yes Yes Yes % right Count 3 50.00% CDN$
Financial Cash Flow CDN$ -$29.188 -$22.844 -$58.464 $31.102 $12.177 -$14.450 -$9.286 C F Statement  Financial Cash Flow CDN$
Total Accruals $6.418 -$8.066 -$2.088 -$72.574 $13.050 -$17.379 -$30.410 Accruals CDN$
Accruals Ratio 1.24% -1.67% -0.50% -17.48% 3.37% -4.97% -9.29% -4.97% <-Median-> 5 Ratio CDN$
Cash CDN$ $79.085 $50.704 $45.437 $14.911 $61.145 $26.243 $26.851 $28.067 $28.900 Cash CDN$
Cash per Share $3.40 $2.01 $1.80 $0.55 $1.97 $0.82 $0.83 $0.87 $0.89 $0.83 <-Median-> 5 Cash per Share CDN$
Percentage of Stock Price 29.63% 19.59% 18.79% 3.73% 7.72% 4.58% 5.52% 8.82% 21.07% 5.52% <-Median-> 5 % of Stock Price
Notes:
May 21, 2023.  Last estimates were in CDN$ for 2022, 2023 and 2024 of $99M, $182M and $275M, -$0.18, $0.80 and $0.92 for EPS, 
$52.4M, $92.9M and $92.9M for FCF, $6.03 and $6.43 for BVPS, and -$9M, $14.4M and $37.3M for Net Income.
May 21, 2022.  Last estimates were for 2021, 2022 and 2023 of $69M, $150M and $242M US$ for Revenue, $0.50, $0.47 and $2.23 for EPS, 
$24.5M, $52.4M and $92.9M US$ for FCF and $-12.5M, $17.7M and 74.7M US$ for Net Income.
May 22, 2021.  Last estimates were for 2020 and 2021 of $59.5M and $76.5M US$ for Revenue, $0.36, $0.29 and 0.29 US$ for EPS for 2020 to 2022 and $9.425M US$ for Net Income
May 16, 2020.  Last estimates were for 2019 and 2020 of $81.3M, $72.1 for Revenue CDN$, $0.05 and $0.34 for EPS CDN$ and $2.09M and $12M for Net Income CDN$.
May 19, 2019.  Last estimates were for 2018, 2019 and 2020 of $82.4M, $81.5M and $56M for Revenue CDN$, -$0.49, -$0.29 and $0.10  for EPS CDN$ and -$10.4M, $-3.96M and $2.86M for Net Income CDN$.
Automular Corp bought into this stock.  Stock values bfore 2015 are for automodular Corp.
August 10, 2018 started to trade on US exchange.
March 23, 2018.  I paid $10.20 for shares in HLS with Automodular Corp shares.
In March 2018 HLS Therapeutics Inc. was listed publicly on the TSXV by way of a Reverse Take-Over of Automodular Corporation.
August 11. 2015.  Privated plancement of 20,000,000 shares for $200,000,000 or $10 a share US$ Exchge 1.3148
Sector:
Health Care, Consumer
What should this stock accomplish?
Would I buy this company and Why.
Why am I following this stock. 
I got this stock because it did a reverse takeover of Automodular Corp (TSX-AM, OTC-AMZKF) on March 12, 2018.  
There was a plan of arrangement whereby Automodular shareholders got 0.165834 HLS common shares and one HLS preferred share.  
The HLS preferred shares were a form of contingent value right allowing AMD shareholders to have an equity stake linked to the 
outcome of litigation that had been ongoing for several years between AMD and General Motors.
I bought some stock in 2018, 2020 and 2023 because this is a Health Care sector stock and there are few of them in the Canadian market.
Dividends
Dividends are paid quarterly in Cycle 1 of January,m April, July and October.  Dividends are declared in one month for shareholders of record of the that month and paid in the next month.
For example, the dividends declared on December 15, 2015 are for shareholders of Record of December 31, 2015 and was paid on January 15, 2016.
This company changed dividends from monthly to quarterly in 2016.
Misson Statement or closes thing I can find.
What I am looking for is a statement that the company wants to do well by their customers, employees, and community and and thereby earn shareholders a reasonable return.
For customers 
For employees 
For community 
For investors 
Why I bought this stock.
How they make their money.
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in 
the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product 
sales and royalties, out of which product sales contribute to most of the revenue. The company operates in Canada, the United States, and the Rest of the world.   
Shares; '%, Value $M Tot Ret Cap Gain Div. Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Shares %, Val $M Change
Date -2.54% -2.65% 0.11% -2.54% Sep 14 2018 May 2019 May 16 2020 May 22 2021 May 21 2022 May 21 2023
Millian, Graig 0.005 0.02%
CEO - Shares - Amount Tot Ret Cap Gain Div. $0.021
Options - percentage 12.86% 12.58% 0.28% 12.86% 0.600 1.85%
Options - amount $2.544
Tot Ret Cap Gain Div. CDN$
Godin, Bilbert 9.75% 9.44% 0.31% 9.75% 0.912 2.87% 0.920 2.84% 0.927 2.87% Ceased insider May 2023 -100.00%
CEO - Shares - Amount $16.416 $13.800 $9.112
Options - percentage Tot Ret Cap Gain Div. US$ 0.714 2.24% 0.839 2.59% 1.180 3.65% -100.00%
Options - amount 11.14% 10.82% 0.32% 11.14% $12.856 $12.589 $11.596
Hendrickson, Tim Tot Ret Cap Gain Div. CDN$ 0.022 0.08% 0.022 0.07% 0.022 0.07% 0.030 0.09% 0.048 0.15% 0.058 0.18% Among Other officers  21.05%
CFO - Shares - Amount 9.23% 7.94% 1.29% 9.23% $0.322 $0.561 $0.396 $0.450 $0.467 $0.244
Options - percentage 5.57% 4.58% 0.99% 5.57% 0.041 0.15% 0.410 1.32% 0.083 0.26% 0.128 0.40% 0.194 0.60% 0.273 0.84% 40.57%
Options - amount $0.600 $10.444 $1.501 $1.926 $1.911 $1.159
Tot Ret Cap Gain Div. US$
Gross, Jason A 9.95% 8.64% 1.31% 9.95% 0.050 0.16% 0.050 0.16% 0.050 0.15% 0.050 0.15% 0.050 0.15% 0.00%
Officer - Shares - Amount 6.70% 5.69% 1.01% 6.70% $1.262 $0.895 $0.746 $0.489 $0.211
Options - percentage 0.093 0.30% 0.105 0.33% 0.133 0.41% 0.144 0.45% 0.159 0.49% 10.43%
Options - amount Tot Ret Cap Gain Div. US$ $2.365 $1.886 $1.992 $1.419 $0.676
2.29% 0.55% 1.74% 2.29%
Daughtery, Carmel maria -1.03% -2.17% 1.15% -1.02% 0.011 0.04% 0.011 0.04% 0.000 0.00% Ceased Inside Feb 2020
Officer - Shares - Amount $0.161 $0.281 $0.000
Options - percentage 0.029 0.11% 0.029 0.09% 0.000 0.00%
Options - amount $0.428 $0.746 $0.000
Bastien, Yvon 0.000 0.00% 0.000 0.00% 0.000 0.00% 0.000 0.00% 0.000 0.00% 0.000 0.00% #DIV/0!
Director - Shares - Amount $0.000 $0.000 $0.000 $0.000 $0.000 $0.000
Options - percentage 0.065 0.24% 0.065 0.21% 0.079 0.25% 0.087 0.27% 0.100 0.31% 0.120 0.37% 20.27%
Options - amount $0.952 $1.657 $1.416 $1.300 $0.979 $0.508
Gubitz, Gregory David 0.667 2.44% 0.667 2.15% 0.912 2.87% 0.325 1.00% 0.225 0.70% 0.050 0.15% Among Other officers  -77.78%
Chairman - Shares - Amt $9.772 $17.009 $16.416 $4.875 $2.212 $0.212 Last filed Apr 2021
Options - percentage 0.607 2.23% 0.607 1.96% 0.654 2.06% 0.808 2.49% 0.821 2.54% 0.843 2.60% No longer CEO 2021 2.66%
Options - amount $8.899 $15.489 $11.776 $12.120 $8.069 $3.573 Dir in 2021, Chair 2023
Wells, William M. 1.252 4.59% 1.252 4.03% 0.962 3.02% 0.942 2.90% 0.839 2.59%
Chairman - Shares - Amt $18.345 $31.932 $17.321 $14.135 $8.243
Options - percentage 0.569 2.08% 0.569 1.83% 0.630 1.98% 0.710 2.19% 0.794 2.45%
Options - amount $8.336 $14.511 $11.341 $10.651 $7.802
Athyrium Opportunities II Co-Invest 1LP 4.125 15.11% 4.125 13.28% 4.352 13.68% 4.352 13.41% 4.352 13.45% 4.352 13.45% reported Jan 2020 0.00%
10% Holder $60.431 $105.188 $78.332 $65.277 $42.778 $18.452
Orbined Aveisors 3.300 12.09% Ceased inisder Aug 2020
10% Holder $48.345
Increase in O/S Shares 0.459 1.82% 0.000 0.00% 0.002 0.01% 0.006 0.02% 0.418 1.29% 0.022 0.07% Zero in 2018
Due to SO $4.391 $0.000 $0.054 $0.111 $6.272 $0.215
Book Value $4.446 $0.000 $0.014 $0.061 $5.332 $0.251
Insider Buying -$0.143 -$0.143 -$0.560 -$0.267 -$0.237 -$0.067
Insider Selling $0.000 $0.000 $5.459 $6.238 $4.049 $2.100
Net Insider Selling -$0.143 -$0.143 $4.898 $5.971 $3.812 $2.033
Net Selling % of Market Cap -0.04% -0.02% 0.86% 1.23% 1.20% 1.48%
Directors 7 7 7 8 10 10
Women 0 0% 1 14% 1 14% 1 13% 2 20% 2 20%
Minorities 0 0% 0 0% 0 0% 0 0% 0 0% 0 0%
Institutions/Holdings 8 76.60% 9 87.61% 20 9.47% 20 24.08% 20 11.61% 20 11.61%
Total Shares Held 20.922 76.65% 23.914 76.99% 2.912 9.15% 7.661 23.61% 3.771 11.65% 3.771 11.65%
Increase/Decrease 3 Mths 0.001 0.00% 3.297 15.99% -0.074 -2.48% -0.059 -0.76% 0.000 0.01% 0.000 0.01%
Starting No. of Shares 20.921 20.617 2.986 7.720 MS Major 20 3.770 MS Major 20 3.770 MS Major 20
Copyright © 2008 Website of SPBrunner. All rights reserved.
My stock  Div